Novelion Therapeutics Inc (NVLN) Inventory Turnover Ratio, from first quarter 2019 to first quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Novelion Therapeutics Inc   (NVLN)
 

Novelion Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novelion Therapeutics Inc inventory turnover ratio, the Novelion Therapeutics Inc 's ability to sell and replace its inventory in the first quarter 2019, sequentially increased to 4.2 in the first quarter 2019, yet the ratio remained below the average, as NVLN's market remain challenging.Average inventory processing period, for the Novelion Therapeutics Inc in Mar 31 2019 quarter, has decreased to 87 days, compare to 89 days, in the Dec 31 2018 quarter.

Within Healthcare sector 124 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2019, to 1039, from total ranking in the fourth quarter 2018 at 1062.

NVLN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novelion Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVLN Inventory Turnover Ratio (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Inventory Growth 0.22 % -19.77 % 21.7 % - -
Y / Y Cost of Sales Growth 12.69 % 5.68 % -57.53 % 9.99 % -17.88 %
Inventory Turnover Ratio (TTM) 4.2 4.08 3.81 5.2 6.61
NVLN's Total Ranking # 1039 # 1062 # 1041 # 1041 # 0
Average inventory processing period 87 89 96 70 55
Seq. Inventory Growth 5.19 % -33.34 % 44.36 % -0.99 % -15.79 %
Seq. Cost of Sales Growth -15.25 % 43.31 % -20.2 % 16.28 % -20.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 37
Healthcare Sector # 125
Overall Market # 1039

Inventory Turnover Ratio Statistics
High Average Low
5.2 4.32 3.81
(Jun 30 2018)   (Sep 30 2018)



NVLN Company Profile >> Back to NVLN Efficiency Comparisons >> Compare NVLN Inventory Turnover Ratio to its Competitors

Financial Statements
Novelion Therapeutics Inc 's Inventories $ 13 Millions Visit NVLN's Balance sheet
Novelion Therapeutics Inc 's Cost of Revenues TTM $ 61 Millions Visit NVLN's Income Statement
What are NVLN's Sales? Visit NVLN's Sales by Segment

Other Inventory Turnover Ratios
Novelion Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVLN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVLN's Competitors
Inventory Turnover Ratio for NVLN's Suppliers
Inventory Turnover Ratio for NVLN's Customers

You may also want to know
NVLN's Sales Growth Rates NVLN's Pe Price to earnings ratio NVLN's Receivables Turnover Ratio NVLN's Stock Quote
NVLN's Net Income Growth Rates NVLN's Ps Price to Sales ratio NVLN's Sales per Employee NVLN's Asset Turnover Ratio
NVLN's Net Margin NVLN's Pb Price to Book ratio NVLN's Financial Strength Ratios NVLN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2019 Inventories at quarter ending Mar 31 2019
Natera Inc   12.37 $ 160.631  Millions$ 13  Millions
Infusystem Holdings Inc  12.18 $ 26.736  Millions$ 2  Millions
Adynxx, Inc.  11.56 $ 1.540  Millions$ 0  Millions
Fonar Corporation  10.64 $ 17.410  Millions$ 2  Millions
Align Technology inc   10.10 $ 555.984  Millions$ 55  Millions
Veracyte Inc   9.86 $ 33.724  Millions$ 3  Millions
Igc Pharma Inc   9.80 $ 4.984  Millions$ 1  Millions
Charles River Laboratories International inc   9.65 $ 1,223.363  Millions$ 127  Millions
Motus Gi Holdings Inc   9.33 $ 0.618  Millions$ 0  Millions
Vericel Corporation  8.85 $ 33.134  Millions$ 4  Millions
Advanced Container Technologies Inc   8.83 $ 1.608  Millions$ 0  Millions
Mallinckrodt Plc  8.78 $ 2,128.200  Millions$ 242  Millions
Hanger inc.  8.76 $ 606.268  Millions$ 69  Millions
Perspective Therapeutics Inc   8.74 $ 4.388  Millions$ 1  Millions
Aeon Global Health Corp.  8.73 $ 3.520  Millions$ 0  Millions
Cytosorbents Corporation  8.52 $ 7.660  Millions$ 1  Millions
Sunlink Health Systems Inc   8.10 $ 16.508  Millions$ 2  Millions
Amag Pharmaceuticals inc   7.96 $ 228.896  Millions$ 29  Millions
Aclaris Therapeutics Inc   7.63 $ 7.090  Millions$ 1  Millions
Dyne Therapeutics Inc   7.62 $ 3,549.000  Millions$ 466  Millions
Ufp Technologies Inc   7.43 $ 144.232  Millions$ 19  Millions
Avalo Therapeutics Inc   7.42 $ 7.367  Millions$ 1  Millions
Catalent Inc   7.32 $ 1,695.600  Millions$ 232  Millions
Harrow Inc   7.30 $ 16.348  Millions$ 2  Millions
Enzo Biochem Inc  7.28 $ 54.588  Millions$ 7  Millions
Kewaunee Scientific Corporation  7.24 $ 121.231  Millions$ 17  Millions
Horizon Therapeutics Public Limited Company  7.18 $ 369.155  Millions$ 51  Millions
Omnova Solutions Inc  7.18 $ 579.000  Millions$ 81  Millions
National Vision Holdings Inc   7.06 $ 745.086  Millions$ 106  Millions
Carlisle Companies Incorporated  6.87 $ 3,352.800  Millions$ 488  Millions

Date modified: 2026-09-08T15:09:34+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.